Search

Search Constraints

You searched for: Author/Creator Jie, Fei

Search Results

1. A multicenter phase II study of sepantronium bromide (YM155) plus rituximab in patients with relapsed aggressive B-cell Non-Hodgkin lymphoma. Issue 8 (2nd August 2016)

3. A phase 2, multicenter, open‐label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma. (23rd December 2014)

8. Estimands for overall survival in clinical trials with treatment switching in oncology. (3rd October 2021)